Psma-pet guided radiation for high-risk prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether using a special PSMA-PET scan to guide radiation therapy can better treat high-risk prostate cancer that hasn't spread. Participants will receive radiation to the prostate along with standard hormone therapy, and doctors will follow their outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and are a man.
- You have been diagnosed with high-risk prostate cancer (for example, PSA 20 or higher, or a high Gleason score).
- The cancer has not spread to lymph nodes or other parts of the body.
- You have not yet started treatment for your prostate cancer (like hormone therapy, chemotherapy, or radiation).
- You have not had surgery to remove your prostate or radiation to your pelvic area before.
- You are willing to commit to hormone therapy and complete questionnaires about your symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET/MR scan to help doctors aim stereotactic radiation more precisely for certain higher-risk or unfavorable intermediate prostate cancers. It studies whether this targeted approach can safely treat the prostate (and specific areas needing extra treatment) without spreading to the body.
This trial uses a special scan (PSMA-PET) to find where prostate cancer has returned after surgery. Then doctors give a lower dose of radiation only to that area, which may reduce side effects. It is for men whose PSA level is rising after prostate removal.
This trial tests whether using a specialized PSMA PET scan to guide radiation can better treat prostate cancer that returns after prostate surgery. It targets the “prostate bed” area with a shorter, stronger radiation schedule (hypofractionated) to control rising PSA levels.
This trial tests a special type of radiation therapy (SBRT) that delivers a higher dose directly to the main tumor in your prostate, guided by a PSMA PET scan. It aims to improve cancer control while limiting side effects.
This trial tests if a special PET scan using PSMA-1007 can find prostate cancer spread in men who have just been diagnosed with high-risk prostate cancer and plan to have surgery. The scan may help doctors better understand the cancer before removing the prostate and lymph nodes.
This early-phase study tests a precise, targeted radiation treatment for prostate cancer, using a special PET scan to help plan exactly where to treat. It may help reduce the amount of radiation to surrounding tissues while treating the cancer.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.